Physician profile
Malathi Bathija
NPI 1124085436
$3,172.97
in general payments reported to CMS, 2019-2025
17 companies · $877 in 2025
The $877 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $228 · 2021: $130 · 2022: $278 · 2023: $430 · 2024: $713 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741 · Education: $258 · Consulting Fee: $21.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.36 |
| Education | $257.72 |
| Consulting Fee | $21.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $571.88 | 2019-2025 | Nucala, Trelegy Ellipta |
| Csl Behring | $518.24 | 2019-2025 | Hizentra, Privigen |
| Takeda Pharmaceuticals U.S.A., INC. | $495.82 | 2021-2025 | Hyqvia, Takhzyro |
| Regeneron Healthcare Solutions, INC. | $372.30 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $328.83 | 2019-2025 | Tezspire |
| Genzyme Corporation | $265.85 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $199.90 | 2024-2025 | |
| Kaleo, INC. | $86.92 | 2019-2022 | |
| Ars Pharmaceuticals Operations, INC. | $51.53 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $50.59 | 2025 | |
| Optinose US, INC. | $45.42 | 2019-2023 | |
| Shire North American Group INC | $45.24 | 2019 | |
| Alk-Abello, INC | $41.76 | 2019-2020 | |
| Genentech USA, INC. | $36.02 | 2019-2024 | Xolair |
| Pharming Healthcare, INC. | $27.91 | 2025 | Ruconest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adma Biomanufacturing LLC | $21.31 | 2025 | |
| Bio Products Laboratory USA, INC. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malathi Bathija listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.